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Abstract
Epi-illuminescence intravital fluorescence microscopy has been employed to study leukocyte-
endothelial interactions in a number of brain pathologies. Historically, dyes such as Rhodamine 
6G have been injected intravenously. However, intravenous injections can predispose 
experimental animals to a multitude of complications and requires a high degree of technical skill. 
Here we study the efficacy of injecting Rhodamine 6G into the peritoneum (IP) for the purpose of 
analyzing leukocyte-endothelial interactions through a cranial window during real time intravital 
microscopy. After examining the number of rolling and adherent leukocytes through a cranial 
window we found no advantage to the intravenous injection (IV). Additionally, we tested blood 
from both routes of injection by flow cytometry to gain a very precise picture of the two methods. 
The two routes of administration failed to show any difference in the ability to detect cells. The 
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study supports the notion that IP Rhodamine 6G works as efficaciously as IV and should be 
considered a viable alternative in experimental design for investigations employing intravital 
microscopy. Facilitated intravital studies will allow for more exploration into cerebral pathologies 
and allow for more rapid translation from the laboratory to the patient with less chance of 
experimental error from failed IV access.
Keywords
Rhodamine 6G; Epi-illuminescence intravital fluorescence microscopy; Intraperitoneal injection; 
Cranial window; Leukocyte Rolling; Leukocyte Adhesion
Introduction
A number of pathologies including cerebral ischemia, multiple sclerosis, infection, and 
traumatic brain injury all cause peripheral leukocytes to enter the brain. Rolling and 
adhesion of peripheral leukocytes remains a necessary process in this entry (Bauer and 
others, 2009; Goldsby and others, 2000; Jin and others, 2010; Kawakami and others, 2012; 
Kenne and others, 2012; Lakhan and others, 2009; Lustig and others, 1992; Zhang and 
others, 2009a; Zhang and others, 2009b). Epi-illuminescence intravital fluorescence 
microscopy allows for visualization and quantification of this process in pial blood vessels 
and has been used to study the process in EAE (Experimental Autoimmune 
Encephalomyelitis), stroke, and other neuroinflammatory conditions (Ramirez and others, 
2012; Zhang and others, 2009a; Zhang and others, 2009b).
Clear visualization of leukocytes and platelets, but not erythrocytes, can be easily achieved 
with administration of fluorescent dyes such as Rhodamine 6G (Gear, 1974; Johnson and 
others, 1980; Ross and Pawlina, 2006). Rhodamine has traditionally been administered 
through IV access (Levene and others, 2007; Zhang and others, 2009b). However, IV access 
in mice poses multiple difficulties and drawbacks. Regardless of the vein accessed, the 
technician must be able to properly cannulate the vessel and no universal method has been 
developed to evaluate this procedure (Groman and Reinhardt, 2004). In mice, the tail vein is 
small and consistent and reliable injections remain difficult to achieve with a failure rate of 
as much as 40% (Groman and Reinhardt, 2004; Levene and others, 2007). Injections to 
vessels in the inner thigh (femoral, saphenous) or neck (jugular) could affect traditional 
motor analysis and gait scoring schemes essential to neuromuscular analysis (Levene and 
others, 2007). Injection to the facial vein avoids many of these risks and if performed 
correctly should prohibit any gait abnormalities (Levene and others, 2007).
However, facial vein injection, as with many other injections sites, requires the use of 
anesthesia to gain surgical access. Anesthetics can induce significant bradycardia as well as 
fluctuations in blood pressure, body temperature, and respiratory rate leading to breathing 
problems (Cox and others, 1994; Olson and others, 1994; Stoenica and others, 2006). Age, 
sex, temperature, nutritional status, and overall health of the animal can also vary the effect 
of anesthesia and therefore experimental findings (Barnes and Eltherington, 1973). While 
anesthesia must be administered for the purpose of intravital microscopy, failed IV 
cannulations lead to longer time under anesthetics as well as bleeding and ultimately 
Reichenbach et al. Page 2









increases the risk of adverse outcomes and the chance of impacting results. Thus, a method 
to administer rhodamine that minimized these risks but also provided reliable and effective 
delivery to allow for epi-illuminescence intravital fluorescence microscopy would be highly 
advantageous.
IP injection satisfied the objectives of relieving the adverse side effects associated with 
surgical IV access. To our knowledge, no one has examined the efficacy of IP rhodamine 
and in particular, for use in intravital microscopy. The IP route had been utilized for 
administration of both fluorescein and Evans Blue dye (Manaenko and others, 2011; Morrey 
and others, 2008). A study comparing intravenous and intraperitoneal Evans Blue dye found 
the results were independent of the administration route (Manaenko and others, 2011). In the 
present study, Rhodamine 6G was administered by both routes and leukocyte-endothelial 
interactions examined through implanted cranial windows. Rolling and adhesion following 
both methods of injection was quantified and showed no difference. Flow cytometry was 
also used to compare staining efficacy following both methods of administration. The 
overall percentage of stained cells did not vary among the samples but IV administration had 
a significantly higher fluorescent mean. However, this difference was eradicated by 
increasing the dose of Rhodamine 6G used for IP injection.
Materials and Methods
Animal treatment methods
This study was carried out in accordance with the National Institutes of Health guidelines 
for the treatment of animals and was approved by the Animal Care and Use Committee at 
Temple University. Male C57Bl/6 (Jackson Laboratories) weighing 20–25g were housed 
with a 12-h light/dark cycle with access to water and food ad libitum. The animals were 
anesthetized with mixture of ketamine (100 mg/mL) and xylazine (20mg/mL) mixed (1:1 by 
volume) at a dose of 1 mL/kg. Body temperature during all surgical procedures was 
maintained with a heating pad and lamp.
Administration of Rhodamine 6G
Freshly prepared 0.05% Rhodamine 6G was administered in an amount of 100 uL except for 
the last set of flow cytometry studies in which 200 uL was administered IP. After the depth 
of anesthesia was confirmed by a lack of toe pinch response, the skin over the inner thigh 
was shaved and prepped for IV injection by swabbing with isopropyl alcohol. A 1 cm 
incision was made to visualize the femoral and saphenous veins. Under a dissecting scope, a 
30 gauge needle was advanced into the lumen of the vein at a distal location. Upon injection 
of rhodamine, displacement of blood in the vessel and visualization of dye in the vessel 
confirmed entry and placement of the needle. Pressure was applied until bleeding stopped 
and the skin was closed with staples.
For IP injection, the needle was inserted at a 30° angle on an imaginary line drawn across 
the abdomen just above the knees of the mice. The needle was inserted along this line on the 
right side of the midline to a depth of 5mm (2005). Aspiration was performed prior to 
injection of Rhodamine 6G to ensure proper placement.
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Implant of cranial windows
The head was shaved and positioned in a stereotactic holder as described in Zhang (Zhang 
and others, 2009a; Zhang and others, 2012). The skin over the right cortical hemisphere was 
swabbed with isopropyl alcohol twice and then removed as well as the periosteum. A 4 mm 
diameter circular craniotomy was performed using an electric high speed drill (Fine Science 
Tools) over the right parietal cortex. It was bounded anteriorly by the coronal suture, 
medially by the sagittal suture, laterally by the attachment of the temporal muscle, and 
posteriorly by the lambdoid suture. The window was positioned in the middle of the sagittal 
suture to include some terminal branches of the middle cerebral artery. Sterile isotonic saline 
was dripped over the cranium to avoid thermal injury of the cortex. The dura was also 
removed and exposed brain kept moist with saline as well. A 5 mm diameter coverglass was 
then implanted over the exposed brain and an airtight seal formed with Nexaband Quick 
Seal. The coverglass provided adequate mechanical protection from infection or 
contamination. A recovery period of 4 days was provided between the implant of the 
windows and the examination of rhodamine application (Zhang and others, 2009a; Zhang 
and others, 2012).
Stimulation of Inflammation and Intravital Microscopy
Since animals in the study lacked pathology, neuroinflammation needed to be initiated to 
quantify rolling and adhesion. Lipopolysaccharide (LPS) from E. coli O111:B4 
(Calbiochem) was dissolved in 1XPBS to a concentration of 1 μg/mL and injected 
intraperitoneally at 5 mg/kg in each animal at the time of Rhodamine 6G administrations for 
studies involving visualization of cerebral vasculature.
Intravital microscopy was carried out as previously described by our laboratory (Zhang and 
others, 2009a; Zhang and others, 2012). Anesthesia was provided and after a lack of toe 
pinch response, the animal was fixed in a stereotactic head holder. An epi-illuminiscence 
microscope with a dichroic mirror (BX10, Olympus, Japan) in combination with a black and 
white digital camera, (Cooke, 1600, Cooke Corporation, Romulus, MI) and a TRITC filter 
(excitation 540 nm, emission 605 nm) was employed to gain a final magnification of 200x 
through the windows. One image was captured every hour for 8 hours to prevent photo-
bleaching and phototoxicity by the mercury lamp. When possible the same vessel was 
examined each time. The collection time was limited to 30 seconds. The images recorded by 
Camware software at a video frame rate of 25 frames/sec and saved as mpeg files for offline 
analysis (Zhang and others, 2009a; Zhang and others, 2012).
Measurement of Leukocyte/Endothelial Interactions
The number of rolling leukocytes was considered to be the total number of leukocytes 
moving at a significantly slower rate than the midline velocity of blood cells as described in 
Zhang (Zhang and others, 2009a; Zhang and others, 2012). They were counted as they 
passed an arbitrary line drawn perpendicular to the long axis of the vessel for 30 seconds. 
This count was repeated 3 times for each vessel with the arbitrary line repositioned each 
time. The average of the 3 counts was reported and normalized to 1 minute with results 
reported as the number of rolling leukocytes/minute.
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Adherent leukocytes were defined as the total number of leukocytes that were firmly 
attached to the endothelium and did not change position during the course of 30 seconds of 
observation (Zhang and others, 2009a; Zhang and others, 2012). Adherent leukocytes were 
reported as the number of cells/mm2. The vascular surface area for each vessel was 
calculated to accomplish this by utilizing ImageJ software (NIH).
Flow Cytometry
To gain a very precise picture of fluorescent activity in individual cells, we utilized flow 
cytometry. Four hours after the administration of Rhodamine 6G, a lancet was utilized to 
perforate the facial vein of the mice and a few drops of blood were collected in 1 mL of PBS 
containing Heparin (750 ng/mL). The samples were centrifuged and resuspended in 2 mL 
RBC Lysis Buffer (eBioSciences). Cells were washed and finally resuspended in 200 μL 1X 
PBS. The samples were analyzed with a BD FACSCalibur flow cytometer and analysis 
performed with Cell Quest Pro software.
Statistical Analysis
Rolling and Adhesions studies, were analyzed with a 2 way analysis of variance for repeated 
measures with Bonferroni correction. Flow cytometry studies were subjected to a Student’s 
t-Test. Data is reported as the Mean ± SEM. A p-value < 0.05 was used for statistical 
significance.
Results
Effect of Injection Method on Number of Observed Rolling and Adherent Leukocytes, 
Figures 1–3
Rolling leukocytes were assessed through the cranial windows every hour for 8 hours, 
Figures 1 and 2. In the IV group, a mean of 43 ± 11 cells/min were observed rolling at 1 
hour and declined to 38 ± 13 cells/min at 8 hours. The IP group exhibited a slightly higher 
mean number of observable cells with 80 ± 33 cells/min at 1 hour and finally 70 ± 25 
cells/min at 8 hours, Figure 2. Two way ANOVA revealed no main effect of route [F(1,66) = 
1.77, ns], no main effect of time [F(7,66) = 0.41, ns], and no significant interaction [F(7,66) = 
0.51, ns]. There was no statistically significant difference between any matched time points. 
Adherent leukocytes were also evaluated between the two injection methods, Figure 3. In 
the IV group, at 1 hour a mean of 732 ± 124 cells/mm2 were found to be adherent compared 
to a mean of 1051 ± 113 cells/mm2 at 8 hours. In the IP group, adherent cells had a mean 
number of 497 ± 153 cells/mm2 at 1 hour and rose to a mean of 1075 ± 138 cells/mm2 at 8 
hours. Two way ANOVA revealed no main effect of route [F(1,66) = 0.14, ns], a main effect 
of time [F(7,66) = 4.01, p < 0.05], and no significant interaction [F(7,66) = 0.62, ns]. In 
comparing the groups, no statistically significant difference was found among any of the 
corresponding time points.
Effect of Injection Method on Flow Cytometry, Figure 4
Blood was extracted from both groups 4 hours after injection and analyzed utilizing flow 
cytometry. When 100 μL was administered, overall staining of leukocytes in the IV group 
had a mean of 85.88% ± 1.70% while in the IP group it was 73.28% ± 5.84%, Figure 4. This 
Reichenbach et al. Page 5









difference was not statistically significant. The fluorescent mean of the IV group was found 
to be 450.29 ± 173.46 compared to 119.182 ± 72.76 in the IP group, Figure 4. This 
difference was statistically significant, p = 0.0123.
Since the fluorescent mean was lower with the IP method, the amount of rhodamine injected 
IP was doubled (200 μL) and compared to the original dose of intravenous rhodamine (100 
μL). In this study, intravenous rhodamine stained a mean of 79.89% ± 5.79% of all 
leukocytes compared to 85.62% ± 6.40% of leukocytes from mice given a double dose 
intraperitoneally, Figure 4. The fluorescent mean was 387.35 ± 44.15 in the IV group and 
365.58 ± 80.49 in the IP group, Figure 4. No statistically significant difference was found.
Discussion
The purpose of the study was to determine if administration of Rhodamine 6G through an IP 
injection would be as efficacious as an IV injection for intravital microscopic observations 
of leukocyte rolling and adhesion. In brief, IP injection proved to be as effective as IV 
injection. Figure 1 clearly demonstrates the ease of identification of leukocytes in each 
method. The importance of this study stems from the high failure rates of IV injection 
(Groman and Reinhardt, 2004). This technique simplifies experimental design and 
minimizes complications.
The number of cells detected was quantified to determine the number of rolling and adherent 
leukocytes. LPS had been injected to create inflammation above baseline and provide a large 
enough sampling of leukocytes. IV administration of rhodamine has been the standard used 
in other publications and it was possible that IP injection would not provide adequate 
staining and underscore the number of rolling cells (Zhang and others, 2009a; Zhang and 
others, 2009b). This was not the case as the IP injection never differed significantly from the 
IV injection method in the number of rolling leukocytes detected. The results were the same 
for measurements of adherent leukocytes. The IP method, again, did not differ in its ability 
to stain and identify cells compared to IV injection. Thus, both methods of injection yield no 
difference in the quantification of rolling and adherent leukocytes and the simplified IP 
method may be beneficial in some experimental designs.
We next performed flow cytometry on blood samples at 4 hours to evaluate the effect of the 
two injection methods on the staining of leukocytes. Our selection of 4 hours was based on 
the fact that it represented the halfway point of our study. Administration of equal amounts 
of rhodamine produced no statistically significant difference in overall stained leukocytes 
but it did produce differences in the fluorescent means with the IV method yielding higher 
values. Despite the difference in fluorescent means, the flow cytometry was still able to 
detect an equivalent number of cells regardless of the injection method. When we doubled 
the amount of rhodamine injected into the peritoneum, 200 μL, no differences were found in 
the overall number of cells stained or the fluorescent mean. Higher amounts of rhodamine in 
IP injections could perhaps increase the concentration gradient and amount of diffusion 
leading to more dye in circulation and ultimately in each leukocyte.
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In summary, it has been shown that regardless of the injection method used, the number of 
rolling and adherent leukocytes in cranial windows remain unchanged based on the injection 
route. Neither method creates a statistically significant different percentage of overall 
stained leukocytes. However, at equal injection volumes, the IV method generates greater 
fluorescent means. This difference is easily averted when the dose administered in the 
peritoneum is doubled. With no difference by either method, the much simpler IP method 
can be considered a viable substitute in some protocols and experimental designs.
Conclusion
Considering the complications associated with IV injection from both the administration of 
anesthesia and the high rate of failure in cannulating the vessels, IP injection should be 
considered as an alternative and equally efficacious method to administer Rhodamine 6G for 
analysis of leukocyte-endothelial interactions in cranial windows during intravital 
microscopy.
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Still images obtained from movies of cerebral blood flow captured by intravital microscopy. 
Top row: Intravenous administration at 1, 4, and 8 hours respectively. Bottom row: 
Intraperitoneal administration of Rhodamine 6G at the same time points. Scale bar is 100 
μM.
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Rolling leukocytes on pial endothelial cells. There was no difference between either group at 
matched time points. Data displayed as Mean ± SEM. p < 0.05. n =3 mice in each group.
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Adherent leukocytes on pial endothelial cells. There was no difference between either group 
at matched time points. Data displayed as Mean ± SEM. p < 0.05. n =3 mice in each group.
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Flow cytometry at 4 hours. Panel A and B, overall percentage of stained cells (A) and 
fluorescent mean (B) with 100 μL of Rhodamine 6G given. There was no difference in the 
overall percent of stained cells, however, there was a statistically significant difference 
among the fluorescent mean. Panel C and D, overall percentage of stained cells (C) and 
fluorescent mean (D) when 200 μL of Rhodamine 6G given. Data expressed as Mean ± 
SEM. p < 0.05. n =5 mice in each group.
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